Venous Multiple Sclerosis Hypothesis | CCSVI

The University at Buffalo, NY announced the "combined transcranial and extracranial venous Doppler" (CTEVD) study. The goal is to check the results of Prof. Zamboni. Prof. Robert Zivadinov leads this study. The new study will involve 1,600 adults and 100 children. The cohort will be comprised of 1,100 patients who were diagnosed with possible or definite MS, 300 age-and-sex matched normal controls, and 300 patients with other autoimmune and neurodegenerative diseases.
Enrollment in the study has begun and will continue for two years. MS patients from across the U.S. are eligible to participate in the study.

Michael Cain, M.D., professor and dean of the UB School of Medicine and Biomedical Sciences, said a positive outcome from this trial would have enormous implications for the treatment of MS.

Press release: Neurologists Investigate Possible New Underlying Cause of MS
TV news: UB leads way in battle against MS
WBFO Public Radio: UB Neurologists try to Pinpoint Cause of Multiple Sclerosis
The Buffalo News: Study could overturn thinking on cause of multiple sclerosis
CTEVD Study Enrollment